Cue Biopharma Stock Price History
| CUE Stock | USD 1.09 0.03 2.83% |
Below is the normalized historical share price chart for Cue Biopharma extending back to January 02, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cue Biopharma stands at 1.09, as last reported on the 27th of November, with the highest price reaching 1.15 and the lowest price hitting 1.03 during the day.
If you're considering investing in Cue Stock, it is important to understand the factors that can impact its price. Cue Biopharma is dangerous given 3 months investment horizon. Cue Biopharma secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11% return per unit of standard deviation over the last 3 months. We are able to break down and analyze data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.27% are justified by taking the suggested risk. Use Cue Biopharma mean deviation of 7.51, and Risk Adjusted Performance of 0.0788 to evaluate company specific risk that cannot be diversified away.
At present, Cue Biopharma's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 24 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 30 M. . As of November 27, 2024, Price To Sales Ratio is expected to decline to 20.90. In addition to that, Price Earnings Ratio is expected to decline to -2.5. Cue Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of January 2018 | 200 Day MA 1.3652 | 50 Day MA 1.1872 | Beta 1.796 |
Cue |
Sharpe Ratio = 0.1056
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CUE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.02 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.27 actual daily | 25 75% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Cue Biopharma is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cue Biopharma by adding it to a well-diversified portfolio.
Price Book 2.5474 | Enterprise Value Ebitda (1.76) | Price Sales 8.0954 | Shares Float 48.2 M | Wall Street Target Price 3.6 |
Cue Biopharma Stock Price History Chart
There are several ways to analyze Cue Stock price data. The simplest method is using a basic Cue candlestick price chart, which shows Cue Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 11, 2024 | 1.87 |
| Lowest Price | September 26, 2024 | 0.45 |
Cue Biopharma November 27, 2024 Stock Price Synopsis
Various analyses of Cue Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cue Stock. It can be used to describe the percentage change in the price of Cue Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cue Stock.| Cue Biopharma Price Rate Of Daily Change | 1.03 | |
| Cue Biopharma Price Daily Balance Of Power | 0.25 | |
| Cue Biopharma Accumulation Distribution | 53,075 | |
| Cue Biopharma Price Action Indicator | 0.02 |
Cue Biopharma November 27, 2024 Stock Price Analysis
Cue Stock Price History Data
The price series of Cue Biopharma for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 1.42 with a coefficient of variation of 41.58. The prices are distributed with arithmetic mean of 1.06. The median price for the last 90 days is 1.08.| Open | High | Low | Close | Volume | ||
| 11/26/2024 | 1.05 | 1.15 | 1.03 | 1.09 | 508,637 | |
| 11/25/2024 | 1.06 | 1.24 | 1.05 | 1.06 | 677,523 | |
| 11/22/2024 | 1.01 | 1.08 | 1.01 | 1.02 | 266,035 | |
| 11/21/2024 | 1.09 | 1.10 | 1.02 | 1.03 | 489,138 | |
| 11/20/2024 | 1.11 | 1.17 | 1.05 | 1.09 | 409,315 | |
| 11/19/2024 | 1.10 | 1.19 | 1.04 | 1.08 | 1,120,845 | |
| 11/18/2024 | 1.25 | 1.37 | 1.05 | 1.10 | 465,470 | |
| 11/15/2024 | 1.50 | 1.56 | 1.24 | 1.25 | 1,208,865 | |
| 11/14/2024 | 1.58 | 1.60 | 1.45 | 1.50 | 1,330,047 | |
| 11/13/2024 | 1.71 | 1.84 | 1.46 | 1.50 | 529,059 | |
| 11/12/2024 | 1.88 | 1.92 | 1.61 | 1.70 | 569,046 | |
| 11/11/2024 | 1.70 | 1.99 | 1.69 | 1.87 | 907,207 | |
| 11/08/2024 | 1.79 | 1.87 | 1.64 | 1.72 | 558,642 | |
| 11/07/2024 | 1.65 | 1.90 | 1.59 | 1.78 | 834,607 | |
| 11/06/2024 | 1.76 | 1.89 | 1.56 | 1.65 | 790,533 | |
| 11/05/2024 | 1.48 | 1.74 | 1.32 | 1.71 | 818,901 | |
| 11/04/2024 | 1.51 | 1.64 | 1.45 | 1.49 | 430,254 | |
| 11/01/2024 | 1.65 | 1.69 | 1.43 | 1.52 | 579,600 | |
| 10/31/2024 | 1.72 | 1.74 | 1.48 | 1.61 | 670,206 | |
| 10/30/2024 | 1.71 | 1.90 | 1.69 | 1.75 | 592,396 | |
| 10/29/2024 | 1.75 | 1.95 | 1.60 | 1.69 | 781,880 | |
| 10/28/2024 | 1.46 | 1.86 | 1.46 | 1.78 | 860,271 | |
| 10/25/2024 | 1.54 | 1.63 | 1.31 | 1.48 | 885,458 | |
| 10/24/2024 | 1.63 | 1.68 | 1.50 | 1.56 | 475,631 | |
| 10/23/2024 | 1.60 | 1.61 | 1.50 | 1.57 | 370,042 | |
| 10/22/2024 | 1.68 | 1.68 | 1.50 | 1.60 | 696,822 | |
| 10/21/2024 | 1.33 | 1.90 | 1.28 | 1.68 | 5,534,473 | |
| 10/18/2024 | 1.15 | 1.23 | 1.10 | 1.21 | 319,840 | |
| 10/17/2024 | 1.07 | 1.14 | 1.04 | 1.11 | 312,463 | |
| 10/16/2024 | 1.08 | 1.14 | 0.99 | 1.07 | 677,978 | |
| 10/15/2024 | 1.23 | 1.28 | 1.11 | 1.12 | 317,472 | |
| 10/14/2024 | 1.20 | 1.24 | 1.17 | 1.21 | 190,580 | |
| 10/11/2024 | 1.31 | 1.38 | 1.18 | 1.23 | 464,650 | |
| 10/10/2024 | 1.16 | 1.46 | 1.12 | 1.33 | 1,053,337 | |
| 10/09/2024 | 1.19 | 1.24 | 0.71 | 1.21 | 1,537,739 | |
| 10/08/2024 | 1.38 | 1.40 | 1.11 | 1.23 | 1,087,358 | |
| 10/07/2024 | 1.19 | 1.45 | 1.15 | 1.39 | 2,325,323 | |
| 10/04/2024 | 0.86 | 1.23 | 0.80 | 1.16 | 6,026,155 | |
| 10/03/2024 | 0.72 | 0.88 | 0.70 | 0.82 | 569,582 | |
| 10/02/2024 | 0.71 | 0.74 | 0.69 | 0.73 | 172,606 | |
| 10/01/2024 | 0.77 | 0.78 | 0.68 | 0.72 | 337,815 | |
| 09/30/2024 | 0.68 | 0.77 | 0.68 | 0.76 | 1,505,970 | |
| 09/27/2024 | 0.46 | 0.71 | 0.45 | 0.68 | 4,104,392 | |
| 09/26/2024 | 0.47 | 0.48 | 0.45 | 0.45 | 322,342 | |
| 09/25/2024 | 0.48 | 0.49 | 0.46 | 0.48 | 159,992 | |
| 09/24/2024 | 0.46 | 0.49 | 0.45 | 0.48 | 308,558 | |
| 09/23/2024 | 0.51 | 0.53 | 0.47 | 0.48 | 246,796 | |
| 09/20/2024 | 0.57 | 0.57 | 0.52 | 0.52 | 200,124 | |
| 09/19/2024 | 0.56 | 0.57 | 0.55 | 0.56 | 186,106 | |
| 09/18/2024 | 0.56 | 0.57 | 0.55 | 0.55 | 125,149 | |
| 09/17/2024 | 0.56 | 0.58 | 0.54 | 0.57 | 197,614 | |
| 09/16/2024 | 0.59 | 0.60 | 0.56 | 0.56 | 78,825 | |
| 09/13/2024 | 0.63 | 0.63 | 0.58 | 0.59 | 149,023 | |
| 09/12/2024 | 0.59 | 0.61 | 0.56 | 0.58 | 225,710 | |
| 09/11/2024 | 0.56 | 0.61 | 0.56 | 0.59 | 122,325 | |
| 09/10/2024 | 0.61 | 0.61 | 0.55 | 0.57 | 173,326 | |
| 09/09/2024 | 0.59 | 0.60 | 0.54 | 0.57 | 300,966 | |
| 09/06/2024 | 0.64 | 0.66 | 0.56 | 0.59 | 260,561 | |
| 09/05/2024 | 0.67 | 0.70 | 0.63 | 0.63 | 191,671 | |
| 09/04/2024 | 0.64 | 0.68 | 0.64 | 0.66 | 105,309 | |
| 09/03/2024 | 0.72 | 0.75 | 0.64 | 0.66 | 254,628 |
About Cue Biopharma Stock history
Cue Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cue is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cue Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cue Biopharma stock prices may prove useful in developing a viable investing in Cue Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 45.8 M | 30 M | |
| Net Loss | -47.7 M | -50.1 M |
Cue Biopharma Quarterly Net Working Capital |
|
Cue Biopharma Stock Technical Analysis
Cue Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Cue Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cue Biopharma's price direction in advance. Along with the technical and fundamental analysis of Cue Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cue to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0788 | |||
| Jensen Alpha | 0.9269 | |||
| Total Risk Alpha | (0.77) | |||
| Sortino Ratio | 0.1415 | |||
| Treynor Ratio | 0.941 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Cue Stock analysis
When running Cue Biopharma's price analysis, check to measure Cue Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cue Biopharma is operating at the current time. Most of Cue Biopharma's value examination focuses on studying past and present price action to predict the probability of Cue Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cue Biopharma's price. Additionally, you may evaluate how the addition of Cue Biopharma to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |